Twice-Daily versus Once-Daily Pramipexole Extended Release Dosage Regimens in Parkinson's Disease

This open-label study aimed to compare once-daily and twice-daily pramipexole extended release (PER) treatment in Parkinson's disease (PD). PD patients on dopamine agonist therapy, but with unsatisfactory control, were enrolled. Existing agonist doses were switched into equivalent PER doses. Su...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Ji Young, Kim, Young Eun, Yang, Hui-Jun, Kim, Han-Joon, Jeon, Beomseok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318624/
https://www.ncbi.nlm.nih.gov/pubmed/28265478
http://dx.doi.org/10.1155/2017/8518929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318624/
https://www.ncbi.nlm.nih.gov/pubmed/28265478
http://dx.doi.org/10.1155/2017/8518929

Ejemplares similares